The Biotech Model

Free tools and short notes on biotech valuation, deal structure, and the business of drug development. Built for CEOs, BD leads, and investors who want the number and the reasoning behind it.

Tools

Deal-structure calculator

Enter upfront, milestones, royalty tier, and probability of success; see the risk-adjusted value split between licensor and licensee.

Coming shortly.

If you’re modeling a real deal, book a call.

Notes

Short, occasional notes on the practical side of biotech deal-making: what AI can and can’t do in a licensing negotiation, how to run a partnering process without a banker, and how to read a pharma’s BD priorities from its 10-K.

First notes arriving soon.

Get the notes and new tools by email

No more than one a month.

[Email sign-up form goes here — MailerLite block.]